Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma

Multiple myeloma (MM) is an incurable B-cell malignancy. Therefore, new targets and drugs are urgently needed to improve patient outcome. Epigenetic aberrations play a crucial role in development and progression in cancer, including MM. To target these aberrations, epigenetic modulating agents, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Maes, Ken, Menu, Eline, Van Valckenborgh, Els, Van Riet, Ivan, Vanderkerken, Karin, De Bruyne, Elke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730337/
https://www.ncbi.nlm.nih.gov/pubmed/24216985
http://dx.doi.org/10.3390/cancers5020430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730337/
https://www.ncbi.nlm.nih.gov/pubmed/24216985
http://dx.doi.org/10.3390/cancers5020430

Ejemplares similares